Ellen Chiniara's most recent trade in Kymera Therapeutics Inc was a trade of 55,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 27,500 | 82,326 | - | 0 | Common Stock | |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 30.33 per share. | 03 Mar 2025 | 1,833 | 80,493 | - | 30.3 | 55,590 | Common Stock |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 31.00 per share. | 03 Mar 2025 | 408 | 80,085 | - | 31.0 | 12,650 | Common Stock |
| Compass Therapeutics Inc | Ellen V. Chiniara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 41.75 per share. | 06 Jan 2025 | 3,129 | 54,826 | - | 41.8 | 130,645 | Common Stock |
| Kymera Therapeutics Inc | Ellen Chiniara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 130,531 | 130,531 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Ellen Chiniara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 21,755 | 55,960 | - | 0 | Common Stock | |
| Compass Therapeutics Inc | Chiniara Ellen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Ellen Chiniara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 22.58 per share. | 04 Jan 2024 | 3,295 | 34,205 | - | 22.6 | 74,416 | Common Stock |
| Compass Therapeutics Inc | Ellen Chiniara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Ellen Chiniara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Ellen Chiniara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 37,500 | 37,500 | - | 0 | Common Stock | |
| Compass Therapeutics Inc | Ellen Chiniara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) |